11.2.4 Pfizer Inc . 11.2.5 Novartis
List of Tables : Table 8-1 : Global - Biologic Erythropoietin Drugs and Their Sales Table 10-1 : Global - Erythropoietin Product Pipeline Table 11-1 : Amgen Inc . - Total Company Revenue ( Billion US $), 2013 , 2014 & 2015 Table 11-2 : Amgen Inc . - Commercialized Erythropoietin Products Table 11-3 : Amgen Inc . - Erythropoietin Product Sales ( Billion US $), 2013 , 2014 & 2015 Table 11-4 : Johnson & Johnson - Total Company Sales ( Billion US $), 2013 , 2014 & 2015 Table 11-5 : Johnson & Johnson - Commercialized Erythropoietin Products
Browse Full Report With TOC @ http :// www . radiantinsights . com / research / epobiosimilars-the-future-of-erythropoietin-market
Table 11-6 : Johnson & Johnson - Erythropoietin Product Sales ( Billion US $), 2013 , 2014 & 2015 Table 11-7 : Roche - Total Company Revenue ( Billion US $), 2013 , 2014 & 2015 Table 11-8 : Roche - Commercialized Erythropoietin Products Table 11-9 : Roche - Erythropoietin Product Sales ( Billion US $), 2013 , 2014 & 2015 Table 11-10 : Pfizer Inc . - Total Company Revenue ( Billion US $), 2013 , 2014 & 2015 Table 11-11 : Pfizer Inc . - Commercialized Erythropoietin Products Table 11-12 : Novartis - Total Company Sales ( Billion US $), 2013 , 2014 & 2015 Table 11-13 : Novartis - Commercialized Erythropoietin Products
List of Figures :
Figure 3-1 : Global - Population above 60 Years ( Billion ), 2013 & 2050
Figure 3-2 : Global - Incidences of Cancer ( Million ), 2015 & 2025
Follow Us :